Summit Global Investments’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,393
Closed -$212K 520
2025
Q1
$212K Buy
8,393
+1,664
+25% +$49.4K 0.02% 406
2024
Q4
$231K Sell
6,729
-1,708
-20% -$77K 0.01% 489
2024
Q3
$417K Sell
8,437
-2,003
-19% -$103K 0.03% 390
2024
Q2
$628K Buy
+10,440
New +$597K 0.04% 305

Other funds holding RXST

Summit Global Investments's RXST Position: Q2 2025 in Review

Summit Global Investments sold out of RxSight (RXST) in Q2 2025, closing a stake of 8,393 shares — an estimated $212K sold.

Summit Global Investments first reported a position in RXST in Q2 2024 and held it in 4 quarters. The position peaked at $628K in Q2 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

  • Summit Global Investments reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
  • Summit Global Investments sold 8,393 RxSight shares in Q2 2025, an estimated $212K.
  • Summit Global Investments first reported a position in RxSight in Q2 2024 and held it in 4 quarters.
  • Summit Global Investments's RxSight position peaked at $628K in Q2 2024.
  • 174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Summit Global Investments's 13F filing for Q2 2025, filed 12 Aug 2025.